Articles From: Imperial Holdings, Inc. Announces Third Quarter 2014 Results Conference Call to Imprivata to Release Q3 2014 Financial Results on November 3, 2014


Imperial Holdings, Inc. (NYSE: IFT) (“Imperial”) announced today that it will host a conference call on Monday, November 10, 2014 at 5:00 p.m. ET to discuss the Company’s third quarter 2014 financial results.
Sign-up for Imperial Holdings, Inc. Announces Third Quarter 2014 Results Conference Call investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0974424001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Metals Corporation: Mount Polley Remediation Update investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979291001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Reports 2014 Third Quarter Financial Results investment picks
http://media.marketwire.com/attachments/201402/226720_Aras_Logo_3003.jpg http://media.marketwire.com/attachments/201409/277952_itg_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146331&ProfileId=051205&sourceType=1 ANDOVER, MA and MUNICH, GERMANY --
Sign-up for Imperial Tobacco Group Selects Aras as Enterprise PLM Backbone investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced financial results for the third quarter ended September 30, 2014.
Sign-up for Imperva Announces Third Quarter 2014 Financial Results investment picks
Imperva, Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced that Kim DeCarlis has joined the company as Chief Marketing Officer (CMO). DeCarlis reports directly to Imperva President and CEO, Anthony Bettencourt, and has global responsibility across the marketing spectrum, including corporate marketing, communications, demand generation, product marketing and marketing operations.
Sign-up for Imperva Appoints Kim DeCarlis Chief Marketing Officer investment picks
Imperva, Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced the appointment of Michael D.
Sign-up for Imperva Names Mike Mooney to New Role of Chief Revenue Officer investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced scheduled participation at the following upcoming investor conferences: A live webcast, as well as the replay, of these presentations will be accessible from the investors page of Imperva’s website at www.imperva.com .
Sign-up for Imperva to Present at Upcoming Investor Conferences investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced scheduled participation at the following upcoming investor conferences: A live webcast, as well as the replay, of these presentations will be accessible from the investors page of Imperva’s website at www.imperva.com .
Sign-up for Imperva to Present at Upcoming Investor Conferences investment picks
2012/12/10
If you're looking to establish a sane, sustainable withdrawal plan, then follow these tips.
Sign-up for Implementing a Total-Return Approach to Retirement Income investment picks
2014/01/30
If you're looking to establish a sane, sustainable withdrawal plan, then follow these tips.
Sign-up for Implementing a Total-Return Approach to Retirement Income investment picks
In December, Royce Focus Trust’s Board of Directors will meet to consider approving a new Investment Advisory Agreement for Royce Focus Trust (Nasdaq: FUND) with Sprott Asset Management, a Toronto-based alternative asset manager.
Sign-up for Important Information About Royce Focus Trust (Nasdaq: FUND) investment picks
2014/10/24
Important Safety Notice: Voluntary Recall of President's Choice® Organics Primavera pasta sauce Canada NewsWire BRAMPTON, ON , Oct.
Sign-up for Important Safety Notice: Voluntary Recall of President's Choice® Organics Primavera pasta sauce investment picks
Patented formulation of alkalized lidocaine and heparin has been prescribed as a compounded drug for individual patients in different dosages in thousands of insurance reimbursed bladder instillation treatments for interstitial cystitis and painful bladder syndrome (IC/PBS) Formulation to form the cornerstone of the Imprimis Defeat IC™ physician and patient education campaign, which is expected to launch in early 2015 SAN DIEGO , Oct.
Sign-up for Imprimis Pharmaceuticals Enters into License Agreement for Patented Urology Formulation investment picks
Dropless Cataract Therapy now available in California, Nevada, Oregon, and Hawaii SAN DIEGO , Dec.
Sign-up for Imprimis Pharmaceuticals Expands Proprietary Ophthalmic Formulations to Four Key Western States investment picks
Dropless cataract surgery created a "buzz" and was a "hot topic" at this year's AAO meeting SAN DIEGO , Oct.
Sign-up for Imprimis Pharmaceuticals Reports on Positive Clinical Findings Presented at the American Academy of Ophthalmology (AAO) Annual Meeting investment picks
2014/11/12
Patent-pending ophthalmic formulation revenues increased over 190% compared to the second quarter 2014 Company will host conference call today at 4:30 p.m. EST (1:30 p.m. PST) *Currently, all Imprimis compounded formulations may only be prescribed pursuant to a physician prescription for an individually identified patient consistent with federal and state laws governing compounded drug formulations.
Sign-up for Imprimis Pharmaceuticals Reports on Third Quarter 2014 Financial Results and Provides Update on Business Developments investment picks
Agreement to acquire Park Compounding marks an important milestone and a significant step forward to achieving nationwide distribution capability for Imprimis' patent-pending ophthalmic and urologic formulations SAN DIEGO , Dec.
Sign-up for Imprimis Pharmaceuticals Signs Agreement to Acquire PCAB-Accredited Pharmacy in California investment picks
Agreement represents the first distributor relationship outside the mainland United States for the company's ophthalmic formulations, which are now available by prescription in 36 states and US territories SAN DIEGO , Nov.
Sign-up for Imprimis Pharmaceuticals Signs Distribution Agreement to Bring Go Dropless™ Proprietary Formulations to Ophthalmologists in Puerto Rico investment picks
SAN DIEGO , Sept.
Sign-up for Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference investment picks
-- Go Dropless™ campaign continues its momentum as cataract surgeons embrace the benefits of "going dropless" for their patients --
Sign-up for Imprimis Pharmaceuticals' Dropless Formulations to be Presented in Multiple Sessions at the 2014 American Academy of Ophthalmology (AAO) Meeting investment picks
Imprivata ® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today introduced Imprivata OneSign ® 5.0 , the newest version of the company’s flagship authentication and access management solution.
Sign-up for Imprivata OneSign 5.0 Expands Capabilities of Healthcare Industry’s Leading Solution for Authentication Management and Virtual Desktop Access investment picks
Within the next two years, 84 percent of organizations adopting Virtual Desktop Infrastructure (VDI) plan to implement single sign-on (SSO), according to new research from Imprivata ® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry.
Sign-up for Imprivata Survey of 335 U.S Hospitals Confirms that Rapid Adoption of Desktop Virtualization with Single Sign-On is Critical to Success investment picks
Imprivata ® (NYSE: IMPR) today announced that members of management will participate in two upcoming investor conferences.
Sign-up for Imprivata to Present at Two Upcoming Investor Conferences investment picks
Imprivata ® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today announced that the company will release the results for its third quarter ended September 30, 2014 after the market closes on Monday, November 3, 2014.
Sign-up for Imprivata to Release Q3 2014 Financial Results on November 3, 2014 investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Imperial Holdings, Inc. Announces Third Quarter 2014 Results Conference Call to Imprivata to Release Q3 2014 Financial Results on November 3, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent